Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EGF Theramed HealthEVAHF 3-Year EBITDA Growth Rate is 69.40% as of Mar. 2026, which is 3% above its 10-year median of 67.50. The stock has 3 warning signs investors should review. Among 526 Healthcare Providers & Services companies, EGF Theramed Health ranks better than 96.58% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 69.40% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 74.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of EGF Theramed Health was 92.40% per year. The lowest was -312.50% per year. And the median was 67.50% per year.
EGF Theramed Health (OTCPK:EVAHF) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
EGF Theramed Health 3-Year EBITDA Growth Rate Related Terms
EVAHF vs VEEV, BTSG, HQY: 3-Year EBITDA Growth Rate Comparison
For the Health Information Services subindustry, EGF Theramed Health's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EGF Theramed Health 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, EGF Theramed Health's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where EGF Theramed Health's 3-Year EBITDA Growth Rate falls into.
EGF Theramed Health 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 69.40% mean?
EGF Theramed Health (EVAHF) has a 3-Year EBITDA Growth Rate of 69.40% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for EGF Theramed Health and its competitors. This is near median its historical median of 67.50. According to the industry distribution chart, EGF Theramed Health ranks #18 out of 526 companies in the Healthcare Providers & Services industry, placing it in the top 3.4%.
Is EGF Theramed Health's 3-Year EBITDA Growth Rate too high?
EGF Theramed Health's current 3-Year EBITDA Growth Rate of 69.40% is near median its 10-year median of 67.50. The Healthcare Providers & Services industry median 3-Year EBITDA Growth Rate is 10.20. EGF Theramed Health's value of 69.40% is 580.4% above this industry median. Based on the distribution chart, EGF Theramed Health ranks #18 out of 526 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers.
How does EGF Theramed Health's 3-Year EBITDA Growth Rate compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, EGF Theramed Health ranks #18 out of 526 companies for 3-Year EBITDA Growth Rate. This places EGF Theramed Health in the top 3% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 10.20. EGF Theramed Health's value of 69.40% is 580.4% above this benchmark. While the company's 10-year median is 67.50 vs. the industry median of 10.20, EGF Theramed Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 10.20, based on 526 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EGF Theramed Health's current 3-Year EBITDA Growth Rate of 69.40% is 580.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for EGF Theramed Health and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 10.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EGF Theramed Health's current 3-Year EBITDA Growth Rate is 69.40%, which is near median its own 10-year median of 67.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EGF Theramed Health stock overvalued right now?
EGF Theramed Health (EVAHF) has a current 3-Year EBITDA Growth Rate of 69.40%. The current 3-Year EBITDA Growth Rate is 69.40%, which is near median its 10-year median of 67.50 and 580.4% above the Healthcare Providers & Services industry median of 10.20. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For EGF Theramed Health (EVAHF), the current 3-Year EBITDA Growth Rate is 69.40% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
EGF Theramed Health Corp is an early-stage development company. It develops products, technologies, and diagnostic tools focused on personalized medical care including research with natural health and wellness products. The products serve the overall goal of improving health and elevating the human condition. It explores many other medical areas including weight loss, skincare and heart disease.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EVAHF has been successfully added to your 
